MedTrace Logo

Analgesic Treatment for Cancer Pain in South East Asia

NCT02664987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2016-10-31

Study results available
· View outcomes & findings →

Summary

This study is planned to investigate the pain control status in cancer patients in 6 South East Asian countries through evaluation of prescription pattern of analgesics, satisfaction of pain control, quality of life and assessment of the adequacy of pain control and relationship among these factors in cancer patients with pain. Cancer pain is undermanaged and it is hoped that this study will be used as a reference for effective cancer pain management in these countries.

Conditions

Interventions

OTHER

Patients receiving cancer pain treatment

Sponsors & Collaborators

  • Mundipharma Pte Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02664987 on ClinicalTrials.gov